Niagen Bioscience, Inc.

NAGENasdaq· Medicinal Chemicals & Botanical Products

Price History

Revenue

$129.4M

▲ 29.9% YoY

Net Income

$17.4M

▲ 103.3% YoY

EPS

$0.20

▲ 81.8% YoY

Cash

$64.8M

▲ 45.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.